These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 9704409)

  • 1. Bcl-2-family proteins: the role of the BH3 domain in apoptosis.
    Kelekar A; Thompson CB
    Trends Cell Biol; 1998 Aug; 8(8):324-30. PubMed ID: 9704409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of apoptosis by BH3 domains in a cell-free system.
    Cosulich SC; Worrall V; Hedge PJ; Green S; Clarke PR
    Curr Biol; 1997 Dec; 7(12):913-20. PubMed ID: 9382837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the anti-apoptotic mechanism of Bcl-B.
    Zhai D; Ke N; Zhang H; Ladror U; Joseph M; Eichinger A; Godzik A; Ng SC; Reed JC
    Biochem J; 2003 Nov; 376(Pt 1):229-36. PubMed ID: 12921534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the BH3 (Bcl-2 homology 3) domain in the regulation of apoptosis and Bcl-2-related proteins.
    Lutz RJ
    Biochem Soc Trans; 2000 Feb; 28(2):51-6. PubMed ID: 10816098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative genomics: the evolutionary history of the Bcl-2 family.
    Lanave C; Santamaria M; Saccone C
    Gene; 2004 May; 333():71-9. PubMed ID: 15177682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BOD (Bcl-2-related ovarian death gene) is an ovarian BH3 domain-containing proapoptotic Bcl-2 protein capable of dimerization with diverse antiapoptotic Bcl-2 members.
    Hsu SY; Lin P; Hsueh AJ
    Mol Endocrinol; 1998 Sep; 12(9):1432-40. PubMed ID: 9731710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins.
    Puthalakath H; Strasser A
    Cell Death Differ; 2002 May; 9(5):505-12. PubMed ID: 11973609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional identification of the apoptosis effector BH3 domain in cellular protein BNIP1.
    Yasuda M; Chinnadurai G
    Oncogene; 2000 May; 19(19):2363-7. PubMed ID: 10822388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteins of the bcl-2 family in apoptosis signalling: from mechanistic insights to therapeutic opportunities.
    Chan SL; Yu VC
    Clin Exp Pharmacol Physiol; 2004 Mar; 31(3):119-28. PubMed ID: 15008953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The C. elegans orthologue ceBNIP3 interacts with CED-9 and CED-3 but kills through a BH3- and caspase-independent mechanism.
    Cizeau J; Ray R; Chen G; Gietz RD; Greenberg AH
    Oncogene; 2000 Nov; 19(48):5453-63. PubMed ID: 11114722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4.
    Huang DC; Adams JM; Cory S
    EMBO J; 1998 Feb; 17(4):1029-39. PubMed ID: 9463381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homology modeling and docking studies of human Bcl-2L10 protein.
    Bhargavi K; Kalyan Chaitanya P; Ramasree D; Vasavi M; Murthy DK; Uma V
    J Biomol Struct Dyn; 2010 Dec; 28(3):379-91. PubMed ID: 20919753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural biology of the Bcl-2 family of proteins.
    Petros AM; Olejniczak ET; Fesik SW
    Biochim Biophys Acta; 2004 Mar; 1644(2-3):83-94. PubMed ID: 14996493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BID: a novel BH3 domain-only death agonist.
    Wang K; Yin XM; Chao DT; Milliman CL; Korsmeyer SJ
    Genes Dev; 1996 Nov; 10(22):2859-69. PubMed ID: 8918887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Bcl-2 family: structures, interactions and targets for drug discovery.
    Kvansakul M; Hinds MG
    Apoptosis; 2015 Feb; 20(2):136-50. PubMed ID: 25398535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptides derived from BH3 domains of Bcl-2 family members: a comparative analysis of inhibition of Bcl-2, Bcl-x(L) and Bax oligomerization, induction of cytochrome c release, and activation of cell death.
    Shangary S; Johnson DE
    Biochemistry; 2002 Jul; 41(30):9485-95. PubMed ID: 12135371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of two strategies for affinity maturation of a BH3 peptide toward pro-survival Bcl-2 proteins.
    Zhang S; Long A; Link AJ
    ACS Synth Biol; 2012 Mar; 1(3):89-98. PubMed ID: 23651073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccinia virus anti-apoptotic F1L is a novel Bcl-2-like domain-swapped dimer that binds a highly selective subset of BH3-containing death ligands.
    Kvansakul M; Yang H; Fairlie WD; Czabotar PE; Fischer SF; Perugini MA; Huang DC; Colman PM
    Cell Death Differ; 2008 Oct; 15(10):1564-71. PubMed ID: 18551131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2 interactions.
    Finnegan NM; Curtin JF; Prevost G; Morgan B; Cotter TG
    Br J Cancer; 2001 Jul; 85(1):115-21. PubMed ID: 11437412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCL-2 family: regulators of cell death.
    Chao DT; Korsmeyer SJ
    Annu Rev Immunol; 1998; 16():395-419. PubMed ID: 9597135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.